Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$266,983,504
-$16,942,656 QoQ
Shares Held
886,900
+3.4% QoQ
Ownership
0.663%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#26
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. ALNY ranks #3 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,983,504 | 886,900 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $283,926,160 | 858,120 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $341,081,103 | 857,742 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $379,916,856 | 833,151 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $271,234,159 | 831,777 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $233,572,698 | 865,020 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $206,804,543 | 878,860 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $202,124,770 | 734,919 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $189,742,905 | 780,835 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $110,530,827 | 739,584 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $146,336,771 | 764,520 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $141,272,668 | 797,700 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $146,722,950 | 772,470 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $152,560,505 | 761,584 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $178,127,941 | 749,539 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $146,915,837 | 733,992 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $107,482,260 | 736,937 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $124,645,787 | 763,340 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $130,477,055 | 769,413 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $147,105,834 | 779,121 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $120,105,935 | 708,506 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $105,922,430 | 750,212 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $96,537,815 | 742,770 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $109,549,147 | 752,398 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $114,791,024 | 775,039 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $75,770,047 | 696,096 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||